Omeros (OMER) Current Assets (2010 - 2026)
Omeros' (OMER) quarterly Current Assets came in at $180.4 million in Q1 2026, up 87.52% year-on-year from $96.2 million in Q1 2025, and down 16.37% quarter-over-quarter from $215.7 million in Q4 2025.
Omeros (OMER) Current Assets (2010 - 2026) Analysis & Trends
Omeros has disclosed Current Assets across 17 years of filings, most recently posting $180.4 million for Q1 2026.
- Current Assets for Q1 2026 came in at $180.4 million, up 87.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.4 million (up 87.52% YoY), and the FY2025 annual result was $215.7 million, up 60.8% from the prior year.
- Current Assets came in at $180.4 million for Q1 2026 at Omeros, down from $215.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $443.2 million in Q4 2022 to a low of $69.6 million in Q2 2025.
- The 5-year median for Current Assets is $210.2 million (2022), against an average of $230.9 million.
- Across the five-year window, Current Assets surged 215.87% in 2022 and plunged 65.77% in 2025, its largest moves.
- Omeros' Current Assets stood at $443.2 million in 2022, then tumbled by 50.84% to $217.9 million in 2023, then tumbled by 38.45% to $134.1 million in 2024, then surged by 60.8% to $215.7 million in 2025, then decreased by 16.37% to $180.4 million in 2026.
- The last three Current Assets figures came in at $180.4 million (Q1 2026), $215.7 million (Q4 2025), and $71.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 180.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.36 Mn |
| Dec 31, 2025 | 215.67 Mn |
| Sep 30, 2025 | 71.81 Mn |
| Jun 30, 2025 | 69.65 Mn |
| Mar 31, 2025 | 96.18 Mn |
| Dec 31, 2024 | 134.12 Mn |
| Sep 30, 2024 | 164.92 Mn |
| Jun 30, 2024 | 202.93 Mn |
| Mar 31, 2024 | 280.96 Mn |
| Dec 31, 2023 | 217.90 Mn |
| Sep 30, 2023 | 351.34 Mn |
| Jun 30, 2023 | 388.56 Mn |
| Mar 31, 2023 | 417.04 Mn |
| Dec 31, 2022 | 443.24 Mn |
| Sep 30, 2022 | 288.55 Mn |
| Jun 30, 2022 | 192.72 Mn |
| Mar 31, 2022 | 210.22 Mn |
| Dec 31, 2021 | 247.96 Mn |
| Sep 30, 2021 | 91.35 Mn |
| Jun 30, 2021 | 112.40 Mn |